{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-043491","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.356210+00:00","generated_at":"2026-05-17T05:04:15.234069+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sanuwave Health appoints Coyle COO, removes Stegagno; terminates President Walko","bullets":["Daniel Coyle appointed COO effective Sept 25, 2025; previously VP of Engineering.","Former COO Peter Stegagno removed, appointed Chief Regulatory Officer; no longer an executive officer.","President Andrew Walko terminated without cause effective Oct 24, 2025; no new President planned.","Coyle's base salary set at $225,000, bonus at 40% of salary, and options for 60,000 shares vesting quarterly."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-043491","json":"https://secwatch.observer/filing/0001628280-25-043491.json","markdown":"https://secwatch.observer/filing/0001628280-25-043491.md","text":"https://secwatch.observer/filing/0001628280-25-043491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025043491/0001628280-25-043491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025043491/snwv-20250925.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:04:15.234069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}